Patents by Inventor Dominique Barbalat-Damour

Dominique Barbalat-Damour has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted thieno[2,3-c]pyrazoles, process for preparing them, compositions containing them, and use thereof
    Patent number: 7884123
    Abstract: Compounds of formula (I), wherein R1 and R3 have the meanings given in the description, said compounds being in all isomeric forms; and salts thereof; processes for the preparation of the compounds and intermediates; compositions containing them, and the use thereof as medicaments, particularly as anti-cancer agents.
    Type: Grant
    Filed: May 23, 2007
    Date of Patent: February 8, 2011
    Assignee: Aventis Pharma S.A.
    Inventors: Jean-Christophe Carry, Gilles Doerflinger, Antony Bigot, Dominique Barbalat-Damour, François Clerc, Arielle Genevois-Borella, Baptiste Ronan, Hervé Minoux, Claude Barberis, Yves Janin
  • Hydrazinocarbonyl-thieno[2,3-C]pyrazoles, process for preparing them, compositions containing them and use thereof
    Patent number: 7595320
    Abstract: The present invention concerns hydrazinocarbonyl-thieno[2,3-c]pyrazoles of formula (I): wherein R1, R3, R4, are R5 are as defined in the disclosure; their preparation method, compositions containing the same and their use for the treatment of pathological conditions, in particular as anticancer agents.
    Type: Grant
    Filed: August 29, 2007
    Date of Patent: September 29, 2009
    Assignee: Aventis Pharma S.A.
    Inventors: Claude Barberis, Jean-Christophe Carry, Gilles Doerflinger, Dominique Barbalat-Damour, Francois Clerc, Herve Minoux
  • Hydrazinocarbonyl-thieno[2,3-C]pyrazoles, Process for Preparing Them, Compositions Containing Them and Use Thereof
    Publication number: 20080146542
    Abstract: The present invention concerns hydrazinocarbonyl-thieno[2,3-c]pyrazoles of formula (I): wherein R1, R3, R4, are R5 are as defined in the disclosure; their preparation method, compositions containing the same and their use for the treatment of pathological conditions, in particular as anticancer agents.
    Type: Application
    Filed: August 29, 2007
    Publication date: June 19, 2008
    Applicant: Aventis Pharma S.A.
    Inventors: Claude BARBERIS, Jean-Christophe CARRY, Gilles DOERFLINGER, Dominique BARBALAT-DAMOUR, Francois CLERC, Herve MINOUX
  • Substituted Thieno[2,3-c]pyrazoles, Process for Preparing Them, Compositions Containing Them, and Use Thereof
    Publication number: 20080058402
    Abstract: Compounds of formula (I), wherein R1 and R3 have the meanings given in the description, said compounds being in all isomeric forms; and salts thereof; processes for the preparation of the compounds and intermediates; compositions containing them, and the use thereof as medicaments, particularly as anti-cancer agents.
    Type: Application
    Filed: May 23, 2007
    Publication date: March 6, 2008
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Jean-Christophe CARRY, Gilles DOERFLINGER, Antony BIGOT, Dominique BARBALAT-DAMOUR, Francois CLERC, Arielle GENEVOIS-BORELLA, Baptiste RONAN, Herve MINOUX, Claude BARBERIS, Yves JANIN